Volume 35, 2 April 2004 | 4/2004 |
SPOT ON | |
Adjuvant treatment of breast cancer: early switch to exemestane (AROMASIN)? | |
NEW ON THE MARKET | |
Fulvestrant (FASLODEX) for advanced breast cancer | |
REVIEW | |
Drug-eluting stents | |
THERAPIES FROM A CRITICAL VIEW POINT | |
Infliximab (REMICADE) for fistulising CROHN's disease | |
QUALITY ASSESSMENT | |
Quality of enalapril (e.g. PRES) products | |
BEWARE! MISSINFORMATION | |
Pimecrolimus (e.g. ELIDEL) for atopic dermatitis | |
IN BRIEF | |
Prematurity and chronic lung disease: late outcomes of dexamethasone therapy | |
CURRENT ADR NETWORK REPORT | |
Long-acting injectable risperidone (RISPERDAL CONSTA): | |
© arznei-telegramm 4/2004 | ||